Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date14 Feb 2020 |
100 Clinical Results associated with Gansu Foge Tibetan Medicine Co., Ltd.
0 Patents (Medical) associated with Gansu Foge Tibetan Medicine Co., Ltd.
100 Deals associated with Gansu Foge Tibetan Medicine Co., Ltd.
100 Translational Medicine associated with Gansu Foge Tibetan Medicine Co., Ltd.